A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia

被引：5

作者：

Berger, Mathilde ^{[1
]}

Amini-Adle, Mona ^{[1
]}

Crumbach, Laura ^{[1
]}

Paubelle, Etienne ^{[2
]}

Dalle, Stephane ^{[1
]}

机构：

[1] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Dermatol, Pierre Benite, France

[2] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Hematol, Pierre Benite, France

来源：

EUROPEAN JOURNAL OF CANCER | 2019年 / 112卷

关键词：

Melanoma; Immunotherapy; Immune checkpoint blocking agents; PD1-inhibitor; Immune related adverse events; Thrombocytopaenia; Pure red cell aplasia; NIVOLUMAB; IMMUNOTHERAPY;

D O I：

10.1016/j.ejca.2019.02.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：94 / 97

页数：4